4.6 Article

Race, APOE genotypes, and cognitive decline among middle-aged urban adults

期刊

ALZHEIMERS RESEARCH & THERAPY
卷 13, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s13195-021-00855-y

关键词

Apolipoprotein E; Cognitive aging; Racial disparities

资金

  1. Intramural Research Program of the NIH, National Institute on Aging [Z01-AG000513]
  2. National Institutes of Health (NIH)
  3. [NIHT32 AG000246]

向作者/读者索取更多资源

The study found that APOE4 dosage was associated with faster decline in cognitive memory tests among Whites, while in African American women, APOE4 dosage showed a potential protective effect in attention tests. However, inconsistent results were observed in other cognitive domains and across racial groups, warranting further longitudinal studies.
Background Associations of Apolipoprotein (APOE) epsilon 2 or epsilon 4 (APOE2 or APOE4) dosages with cognitive change may differ across racial groups. Methods Longitudinal data on 1770 middle-aged White and African American adults was compiled from the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS 2004-2013) study. APOE2 and APOE4 dosages were the two main exposures, while v(1) and annual rate of change in cognitive performance (between v(1) and v(2)) on 11 test scores were the main outcomes of interest (v1: 2004-2009 and v2: 2009-2013). Mixed-effects linear regression models were conducted adjusting for socio-demographic, lifestyle, and health-related potential confounders. Race (African American vs. White) and sex within racial groups were main effect modifiers. Results Upon adjustment for multiple testing and potential confounders, APOE4 allelic dosage was associated with faster decline on a test of verbal memory among Whites only (CVLT-List A: gamma(12) = - 0.363 +/- 0.137, p = 0.008), but not among African Americans. In contrast, among African American women, APOE4 dosage was linked to slower decline on a test of attention (BTA: gamma(12) = + 0.106 +/- 0.035, p = 0.002), while no association was detected among African American men. APOE2 and APOE4 dosages showed inconsistent results in other domains of cognition overall and across racial groups that did not survive correction for multiple testing. Conclusions In conclusion, APOE4 dosage was associated with faster decline on a test of verbal memory among Whites only, while exhibiting a potential protective effect among African American women in the domain of attention. Further longitudinal studies are needed to replicate our race and sex-specific findings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据